drugset / Trial / NCT05702177

A Study of the Effect of Daridorexant on Nighttime Body Posture, the Noise Level Required to Wake up, and the Ability to Remember Words Previously Presented

NCT05702177

Phase 1 Completed 36 enrolled Idorsia Pharmaceuticals Ltd.
RandomizedCrossoverQuadruple-blindOther

Summary

A Study of the Effect of Daridorexant on Nighttime Body Posture, the Noise Level Required to Wake up, and the Ability to Remember Words Previously Presented

Timeline

Start
2023-01-05
Primary completion
2023-04-25
Completion
2023-04-25

Drugs

EvaluationDrugModalityDoseRoute
Subject Daridorexant Small molecule 25 mg Oral
Subject Daridorexant Small molecule 50 mg Oral

Indications

No indication recorded.